Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lucentis
Pharma
FDA gives thumbs-up to Roche's Susvimo as treatment for DME
The FDA has broadened the label of Roche's eye implant Susvimo to treat diabetic macular edema, the leading cause of diabetes-related blindness.
Kevin Dunleavy
Feb 4, 2025 3:15pm
Italy opens antitrust case against Novartis, Biogen and others
Jun 6, 2024 11:39am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
Sandoz buys Coherus' Lucentis biosimilar Cimerli for $170M
Jan 22, 2024 11:55am
Novartis targets Xiidra in eye disease asset sale: Bloomberg
Mar 14, 2023 10:22am
Novartis, Roche avoid $475M fine in French appeals court
Feb 17, 2023 11:41am
